[Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy].
Identifieur interne : 000139 ( France/Analysis ); précédent : 000138; suivant : 000140[Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy].
Auteurs : J. Jacob [France] ; L. Belin ; A. Gobillion ; C. Daveau-Bergerault ; R. Dendale ; P. Beuzeboc ; F. Campana ; M-A Bollet ; A. Fourquet ; Y M KirovaSource :
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [ 1769-6658 ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Anticorps monoclonaux humanisés (administration et posologie), Anticorps monoclonaux humanisés (effets indésirables), Antinéoplasiques (administration et posologie), Antinéoplasiques (effets indésirables), Carcinome canalaire du sein (), Carcinome canalaire du sein (mortalité), Chimioradiothérapie (effets indésirables), Douleur (étiologie), Débit systolique (), Débit systolique (effets des radiations), Femelle, Fibrose (étiologie), Humains, Lymphoedème (étiologie), Mastectomie, Mastectomie partielle, Oesophagite (étiologie), Peau (anatomopathologie), Radiodermite (étiologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Trastuzumab, Tumeurs du sein (), Tumeurs du sein (mortalité), Télangiectasie (étiologie), Études prospectives.
- MESH :
- administration et posologie : Anticorps monoclonaux humanisés, Antinéoplasiques.
- anatomopathologie : Peau.
- effets des radiations : Débit systolique.
- effets indésirables : Anticorps monoclonaux humanisés, Antinéoplasiques, Chimioradiothérapie.
- mortalité : Carcinome canalaire du sein, Tumeurs du sein.
- étiologie : Douleur, Fibrose, Lymphoedème, Oesophagite, Radiodermite, Télangiectasie.
- Adulte, Adulte d'âge moyen, Carcinome canalaire du sein, Débit systolique, Femelle, Humains, Mastectomie, Mastectomie partielle, Sujet âgé, Sujet âgé de 80 ans ou plus, Trastuzumab, Tumeurs du sein, Études prospectives.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized (administration & dosage), Antibodies, Monoclonal, Humanized (adverse effects), Antineoplastic Agents (administration & dosage), Antineoplastic Agents (adverse effects), Breast Neoplasms (mortality), Breast Neoplasms (therapy), Carcinoma, Ductal, Breast (mortality), Carcinoma, Ductal, Breast (therapy), Chemoradiotherapy (adverse effects), Esophagitis (etiology), Female, Fibrosis (etiology), Humans, Lymphedema (etiology), Mastectomy, Mastectomy, Segmental, Middle Aged, Pain (etiology), Prospective Studies, Radiodermatitis (etiology), Skin (pathology), Stroke Volume (drug effects), Stroke Volume (radiation effects), Telangiectasis (etiology), Trastuzumab.
- MESH :
- chemical , administration & dosage : Antibodies, Monoclonal, Humanized, Antineoplastic Agents.
- chemical , adverse effects : Antibodies, Monoclonal, Humanized, Antineoplastic Agents.
- adverse effects : Chemoradiotherapy.
- drug effects : Stroke Volume.
- etiology : Esophagitis, Fibrosis, Lymphedema, Pain, Radiodermatitis, Telangiectasis.
- mortality : Breast Neoplasms, Carcinoma, Ductal, Breast.
- pathology : Skin.
- radiation effects : Stroke Volume.
- therapy : Breast Neoplasms, Carcinoma, Ductal, Breast.
- Adult, Aged, Aged, 80 and over, Female, Humans, Mastectomy, Mastectomy, Segmental, Middle Aged, Prospective Studies, Trastuzumab.
Abstract
Prospective monocentric study of the toxicities related to concurrent administration of trastuzumab to breast radiotherapy.
DOI: 10.1016/j.canrad.2012.12.006
PubMed: 23499212
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001C52
- to stream PubMed, to step Curation: 001C52
- to stream PubMed, to step Checkpoint: 001C52
- to stream Ncbi, to step Merge: 005707
- to stream Ncbi, to step Curation: 005707
- to stream Ncbi, to step Checkpoint: 005707
- to stream Main, to step Merge: 002F31
- to stream Main, to step Curation: 002F26
- to stream Main, to step Exploration: 002F26
- to stream France, to step Extraction: 000139
Links to Exploration step
pubmed:23499212Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy].</title>
<author><name sortKey="Jacob, J" sort="Jacob, J" uniqKey="Jacob J" first="J" last="Jacob">J. Jacob</name>
<affiliation wicri:level="3"><nlm:affiliation>Département de radiothérapie, institut Curie, 26, rue d'Ulm, 75005 Paris, France. julian.jacob28@gmail.com</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de radiothérapie, institut Curie, 26, rue d'Ulm, 75005 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Belin, L" sort="Belin, L" uniqKey="Belin L" first="L" last="Belin">L. Belin</name>
</author>
<author><name sortKey="Gobillion, A" sort="Gobillion, A" uniqKey="Gobillion A" first="A" last="Gobillion">A. Gobillion</name>
</author>
<author><name sortKey="Daveau Bergerault, C" sort="Daveau Bergerault, C" uniqKey="Daveau Bergerault C" first="C" last="Daveau-Bergerault">C. Daveau-Bergerault</name>
</author>
<author><name sortKey="Dendale, R" sort="Dendale, R" uniqKey="Dendale R" first="R" last="Dendale">R. Dendale</name>
</author>
<author><name sortKey="Beuzeboc, P" sort="Beuzeboc, P" uniqKey="Beuzeboc P" first="P" last="Beuzeboc">P. Beuzeboc</name>
</author>
<author><name sortKey="Campana, F" sort="Campana, F" uniqKey="Campana F" first="F" last="Campana">F. Campana</name>
</author>
<author><name sortKey="Bollet, M A" sort="Bollet, M A" uniqKey="Bollet M" first="M-A" last="Bollet">M-A Bollet</name>
</author>
<author><name sortKey="Fourquet, A" sort="Fourquet, A" uniqKey="Fourquet A" first="A" last="Fourquet">A. Fourquet</name>
</author>
<author><name sortKey="Kirova, Y M" sort="Kirova, Y M" uniqKey="Kirova Y" first="Y M" last="Kirova">Y M Kirova</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23499212</idno>
<idno type="pmid">23499212</idno>
<idno type="doi">10.1016/j.canrad.2012.12.006</idno>
<idno type="wicri:Area/PubMed/Corpus">001C52</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C52</idno>
<idno type="wicri:Area/PubMed/Curation">001C52</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C52</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C52</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C52</idno>
<idno type="wicri:Area/Ncbi/Merge">005707</idno>
<idno type="wicri:Area/Ncbi/Curation">005707</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005707</idno>
<idno type="wicri:Area/Main/Merge">002F31</idno>
<idno type="wicri:Area/Main/Curation">002F26</idno>
<idno type="wicri:Area/Main/Exploration">002F26</idno>
<idno type="wicri:Area/France/Extraction">000139</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy].</title>
<author><name sortKey="Jacob, J" sort="Jacob, J" uniqKey="Jacob J" first="J" last="Jacob">J. Jacob</name>
<affiliation wicri:level="3"><nlm:affiliation>Département de radiothérapie, institut Curie, 26, rue d'Ulm, 75005 Paris, France. julian.jacob28@gmail.com</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de radiothérapie, institut Curie, 26, rue d'Ulm, 75005 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Belin, L" sort="Belin, L" uniqKey="Belin L" first="L" last="Belin">L. Belin</name>
</author>
<author><name sortKey="Gobillion, A" sort="Gobillion, A" uniqKey="Gobillion A" first="A" last="Gobillion">A. Gobillion</name>
</author>
<author><name sortKey="Daveau Bergerault, C" sort="Daveau Bergerault, C" uniqKey="Daveau Bergerault C" first="C" last="Daveau-Bergerault">C. Daveau-Bergerault</name>
</author>
<author><name sortKey="Dendale, R" sort="Dendale, R" uniqKey="Dendale R" first="R" last="Dendale">R. Dendale</name>
</author>
<author><name sortKey="Beuzeboc, P" sort="Beuzeboc, P" uniqKey="Beuzeboc P" first="P" last="Beuzeboc">P. Beuzeboc</name>
</author>
<author><name sortKey="Campana, F" sort="Campana, F" uniqKey="Campana F" first="F" last="Campana">F. Campana</name>
</author>
<author><name sortKey="Bollet, M A" sort="Bollet, M A" uniqKey="Bollet M" first="M-A" last="Bollet">M-A Bollet</name>
</author>
<author><name sortKey="Fourquet, A" sort="Fourquet, A" uniqKey="Fourquet A" first="A" last="Fourquet">A. Fourquet</name>
</author>
<author><name sortKey="Kirova, Y M" sort="Kirova, Y M" uniqKey="Kirova Y" first="Y M" last="Kirova">Y M Kirova</name>
</author>
</analytic>
<series><title level="j">Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</title>
<idno type="eISSN">1769-6658</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antibodies, Monoclonal, Humanized (administration & dosage)</term>
<term>Antibodies, Monoclonal, Humanized (adverse effects)</term>
<term>Antineoplastic Agents (administration & dosage)</term>
<term>Antineoplastic Agents (adverse effects)</term>
<term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Carcinoma, Ductal, Breast (mortality)</term>
<term>Carcinoma, Ductal, Breast (therapy)</term>
<term>Chemoradiotherapy (adverse effects)</term>
<term>Esophagitis (etiology)</term>
<term>Female</term>
<term>Fibrosis (etiology)</term>
<term>Humans</term>
<term>Lymphedema (etiology)</term>
<term>Mastectomy</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Pain (etiology)</term>
<term>Prospective Studies</term>
<term>Radiodermatitis (etiology)</term>
<term>Skin (pathology)</term>
<term>Stroke Volume (drug effects)</term>
<term>Stroke Volume (radiation effects)</term>
<term>Telangiectasis (etiology)</term>
<term>Trastuzumab</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anticorps monoclonaux humanisés (administration et posologie)</term>
<term>Anticorps monoclonaux humanisés (effets indésirables)</term>
<term>Antinéoplasiques (administration et posologie)</term>
<term>Antinéoplasiques (effets indésirables)</term>
<term>Carcinome canalaire du sein ()</term>
<term>Carcinome canalaire du sein (mortalité)</term>
<term>Chimioradiothérapie (effets indésirables)</term>
<term>Douleur (étiologie)</term>
<term>Débit systolique ()</term>
<term>Débit systolique (effets des radiations)</term>
<term>Femelle</term>
<term>Fibrose (étiologie)</term>
<term>Humains</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie</term>
<term>Mastectomie partielle</term>
<term>Oesophagite (étiologie)</term>
<term>Peau (anatomopathologie)</term>
<term>Radiodermite (étiologie)</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Trastuzumab</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Télangiectasie (étiologie)</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
<term>Antineoplastic Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
<term>Antineoplastic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term>
<term>Antinéoplasiques</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Chemoradiotherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Peau</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Stroke Volume</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Débit systolique</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term>
<term>Antinéoplasiques</term>
<term>Chimioradiothérapie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Esophagitis</term>
<term>Fibrosis</term>
<term>Lymphedema</term>
<term>Pain</term>
<term>Radiodermatitis</term>
<term>Telangiectasis</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma, Ductal, Breast</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Carcinome canalaire du sein</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Skin</term>
</keywords>
<keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Stroke Volume</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma, Ductal, Breast</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Douleur</term>
<term>Fibrose</term>
<term>Lymphoedème</term>
<term>Oesophagite</term>
<term>Radiodermite</term>
<term>Télangiectasie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Mastectomy</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Trastuzumab</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Carcinome canalaire du sein</term>
<term>Débit systolique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mastectomie</term>
<term>Mastectomie partielle</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Trastuzumab</term>
<term>Tumeurs du sein</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Prospective monocentric study of the toxicities related to concurrent administration of trastuzumab to breast radiotherapy.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Belin, L" sort="Belin, L" uniqKey="Belin L" first="L" last="Belin">L. Belin</name>
<name sortKey="Beuzeboc, P" sort="Beuzeboc, P" uniqKey="Beuzeboc P" first="P" last="Beuzeboc">P. Beuzeboc</name>
<name sortKey="Bollet, M A" sort="Bollet, M A" uniqKey="Bollet M" first="M-A" last="Bollet">M-A Bollet</name>
<name sortKey="Campana, F" sort="Campana, F" uniqKey="Campana F" first="F" last="Campana">F. Campana</name>
<name sortKey="Daveau Bergerault, C" sort="Daveau Bergerault, C" uniqKey="Daveau Bergerault C" first="C" last="Daveau-Bergerault">C. Daveau-Bergerault</name>
<name sortKey="Dendale, R" sort="Dendale, R" uniqKey="Dendale R" first="R" last="Dendale">R. Dendale</name>
<name sortKey="Fourquet, A" sort="Fourquet, A" uniqKey="Fourquet A" first="A" last="Fourquet">A. Fourquet</name>
<name sortKey="Gobillion, A" sort="Gobillion, A" uniqKey="Gobillion A" first="A" last="Gobillion">A. Gobillion</name>
<name sortKey="Kirova, Y M" sort="Kirova, Y M" uniqKey="Kirova Y" first="Y M" last="Kirova">Y M Kirova</name>
</noCountry>
<country name="France"><region name="Île-de-France"><name sortKey="Jacob, J" sort="Jacob, J" uniqKey="Jacob J" first="J" last="Jacob">J. Jacob</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000139 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000139 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= France |étape= Analysis |type= RBID |clé= pubmed:23499212 |texte= [Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i -Sk "pubmed:23499212" \ | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |